Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 414

1.

[Current situation and trends in the hepatitis C virus genotype distribution among injecting drug users in the Czech Republic].

Krekulová L, Rehák V, Strunecký O, Nēmecek V.

Epidemiol Mikrobiol Imunol. 2009 Apr;58(2):84-9. Czech.

PMID:
19526922
[PubMed - indexed for MEDLINE]
2.

[Genotypic heterogeneity of hepatitis C virus (HCV) from blood donors in the Czech Republic].

Nēmecek V, Strunecký O.

Epidemiol Mikrobiol Imunol. 2009 Apr;58(2):63-72. Czech.

PMID:
19526920
[PubMed - indexed for MEDLINE]
3.

Hepatitis C virus (HCV) 5'NC sequence variants and their association with hepatitis C risk groups.

Krekulova L, Rehak V, Riley LW.

J Clin Virol. 2005 Apr;32(4):300-4.

PMID:
15780809
[PubMed - indexed for MEDLINE]
4.

Distribution of hepatitis C virus genotypes among injecting drug users in contact with treatment centers in Belgium, 2004-2005.

Micalessi MI, Gérard C, Ameye L, Plasschaert S, Brochier B, Vranckx R.

J Med Virol. 2008 Apr;80(4):640-5. doi: 10.1002/jmv.21145.

PMID:
18297717
[PubMed - indexed for MEDLINE]
5.

Prevalence, risk factors and genotypes of hepatitis C virus infection among drug users, Central-Western Brazil.

Lopes CL, Teles SA, Espírito-Santo MP, Lampe E, Rodrigues FP, Motta-Castro AR, Marinho TA, Reis NR, Silva AM, Martins RM.

Rev Saude Publica. 2009 Aug;43 Suppl 1:43-50.

PMID:
19669064
[PubMed - indexed for MEDLINE]
Free Article
6.

Hepatitis C virus molecular epidemiology in Uzbekistan.

Kurbanov F, Tanaka Y, Sugauchi F, Kato H, Ruzibakiev R, Zalyalieva M, Yunusova Z, Mizokami M.

J Med Virol. 2003 Mar;69(3):367-75.

PMID:
12526047
[PubMed - indexed for MEDLINE]
7.

Hepatitis C prevalence among Australian injecting drug users in the 1970s and profiles of virus genotypes in the 1970s and 1990s.

Freeman AJ, Zekry A, Whybin LR, Harvey CE, van Beek IA, de Kantzow SL, Rawlinson WD, Boughton CR, Robertson PW, Marinos G, Lloyd AR.

Med J Aust. 2000 Jun 19;172(12):588-91.

PMID:
10914104
[PubMed - indexed for MEDLINE]
8.

Identification and phylogenetic analysis of hepatitis C virus in forensic blood samples obtained from injecting drug users.

Kato H, Maeno Y, Seko-Nakamura Y, Monma-Ohtaki J, Sugiura S, Takahashi K, Zhe LX, Matsumoto T, Kurvanov F, Mizokami M, Nagao M.

Forensic Sci Int. 2007 May 3;168(1):27-33. Epub 2006 Jul 7.

PMID:
16829004
[PubMed - indexed for MEDLINE]
9.

Molecular epidemiologic analysis of hepatitis C virus infection in injecting drug users with acute hepatitis C in Japan.

Satoh Y, Hino K, Kato T, Mizokami M, Yamashita S, Nakamura H, Okita K.

J Gastroenterol Hepatol. 2004 Nov;19(11):1305-11.

PMID:
15482539
[PubMed - indexed for MEDLINE]
10.

Shift in predominating subtype of HCV from 1b to 3a in St. Petersburg mediated by increase in injecting drug use.

Kalinina O, Norder H, Vetrov T, Zhdanov K, Barzunova M, Plotnikova V, Mukomolov S, Magnius LO.

J Med Virol. 2001 Nov;65(3):517-24.

PMID:
11596087
[PubMed - indexed for MEDLINE]
11.

Genotypic and epidemiologic characteristics of hepatitis C virus infections among recent injection drug user and nonuser populations.

Krekulova L, Rehak V, Madrigal N, Johnson M, Killoran P, Riley LW.

Clin Infect Dis. 2001 Oct 15;33(8):1435-8. Epub 2001 Sep 17.

PMID:
11565087
[PubMed - indexed for MEDLINE]
Free Article
12.

Hepatitis C virus recombinants are rare even among intravenous drug users.

Viazov S, Ross SS, Kyuregyan KK, Timm J, Neumann-Haefelin C, Isaeva OV, Popova OE, Dmitriev PN, El Sharkawi F, Thimme R, Michailov MI, Roggendorf M.

J Med Virol. 2010 Feb;82(2):232-8. doi: 10.1002/jmv.21631.

PMID:
20029799
[PubMed - indexed for MEDLINE]
13.

Changes in the prevalence of hepatitis C virus genotype among Italian injection drug users-relation to period of injection started.

Sereno S, Perinelli P, Laghi V.

J Clin Virol. 2009 Aug;45(4):354-7. doi: 10.1016/j.jcv.2009.04.022. Epub 2009 Jun 3.

PMID:
19497783
[PubMed - indexed for MEDLINE]
14.

Hepatitis C virus genotype distribution among intravenous drug user and the general population in Hong Kong.

Zhou DX, Tang JW, Chu IM, Cheung JL, Tang NL, Tam JS, Chan PK.

J Med Virol. 2006 May;78(5):574-81.

PMID:
16555294
[PubMed - indexed for MEDLINE]
15.

HCV genotype analysis in HCV-HIV-co-infected Puerto Ricans who are injecting drug users: undetermined and mixed infections.

Ríos-Olivares E, Yamamura Y, Gómez MA, Guzmán L, Rodríguez N, Fernández D, Hunter Mellado R.

Cell Mol Biol (Noisy-le-grand). 2001 Sep;47(6):1017-24.

PMID:
11785651
[PubMed - indexed for MEDLINE]
16.

Detection of multiple hepatitis C virus genotypes in a cohort of injecting drug users.

Bowden S, McCaw R, White PA, Crofts N, Aitken CK.

J Viral Hepat. 2005 May;12(3):322-4.

PMID:
15850474
[PubMed - indexed for MEDLINE]
17.

Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy.

Ansaldi F, Bruzzone B, Salmaso S, Rota MC, Durando P, Gasparini R, Icardi G.

J Med Virol. 2005 Jul;76(3):327-32.

PMID:
15902713
[PubMed - indexed for MEDLINE]
18.

Prevalence and genotypes of hepatitis C virus among injecting drug users from Salvador-BA, Brazil.

Silva MB, Andrade TM, Silva LK, Rodart IF, Lopes GB, Carmo TM, Zarife MA, Dourado I, Reis MG.

Mem Inst Oswaldo Cruz. 2010 May;105(3):299-303.

PMID:
20512243
[PubMed - indexed for MEDLINE]
Free Article
19.

Trends in HCV prevalence, risk factors and distribution of viral genotypes in injecting drug users: findings from two cross-sectional studies.

Oliveira ML, Yoshida CF, Telles PR, Hacker MA, Oliveira SA, Miguel JC, do O KM, Bastos FI.

Epidemiol Infect. 2009 Jul;137(7):970-9. doi: 10.1017/S0950268808001970. Epub 2009 Jan 15.

PMID:
19144250
[PubMed - indexed for MEDLINE]
20.

Treatment of chronic hepatitis C in injecting drug users: 5 years' follow-up.

Dalgard O, Bjøro K, Hellum K, Myrvang B, Skaug K, Gutigard B, Bell H; Construct Group.

Eur Addict Res. 2002 Jan;8(1):45-9.

PMID:
11818693
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk